Effects of Pitavastatin on Adiponectin in Patients with Hyperlipidemia
Authors:
- S. NomuraSNS. Nomura
- A. ShouzuASA. Shouzu
- S. OmotoSOS. Omoto
- Y. KimuraYKY. Kimura
- N. TakahashiNTN. Takahashi
- A. TanakaATA. Tanaka
- M. NanbaMNM. Nanba
- Y. ShoudaYSY. Shouda
- T. IwasakaTIT. Iwasaka
- 1 January 2007
- journal article
- research article
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 36 (1) , 1-8
Abstract
The effects of treatment with pitavastatin on inflammatory and platelet activation markers and adiponectin in 117 patients with hyperlipidemia were investigated to determine whether pitavastatin may prevent the progression of atherosclerotic changes in hyperlipidemic patients. Adiponectin levels prior to pitavastatin treatment in hyperlipidemic patients with and without diabetes were lower than levels in normolipidemic controls. Both total cholesterol and the low-density lipoprotein cholesterol decreased significantly after pitavastatin administration. Additionally, hyperlipidemic patients with or without type 2 diabetes exhibited a significant increase in adiponectin levels 6 months after pitavastatin treatment (diabetes: 3.52 ± 0.80 vs. 4.52 ± 0.71 µg/ml, p < 0.001; no diabetes: 3.48 ± 0.71 vs. 4.23 ± 0.82 µg/ml, p < 0.05). However, high-sensitivity C-reactive protein, platelet-derived microparticle and soluble P-selectin did not exhibit any differences before or after pitavastatin administration. Levels of adiponectin significantly increased after pitavastatin administration in the group of lower soluble P-selectin (soluble P-selectin before pitavastatin treatment <200 ng/ml). These results suggest that pitavastatin possesses an adiponectin-increasing effect in patients with hyperlipidemia and this effect is influenced by intensive platelet activation.Keywords
This publication has 46 references indexed in Scilit:
- Sagittal Spinal Posture After Pilates-Based Exercise in Healthy Older AdultsSpine, 2009
- Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytesBiochemical and Biophysical Research Communications, 2006
- Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cellsClinical Science, 2005
- Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cellsLife Sciences, 2005
- Pitavastatin Inhibits Remnant Lipoprotein-Induced Macrophage Foam Cell Formation Through ApoB48 Receptor–Dependent MechanismArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive PatientsCirculation, 2004
- Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetesAtherosclerosis, 2004
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.Journal of Clinical Investigation, 1997
- Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist.Hypertension, 1991